Horizon Therapeutics has had its drug Tepezza, which is the first ever treatment for thyroid eye disease, approved by The US Food and Drug Administration (FDA). Read more
Patient receives first wireless retinal device implant
A surgeon at the University of Pittsburgh Medical Center (UPMC) has implanted the first patient in the US with a new wireless retinal device. Read more
Safilo introduces new David Beckham range to Australia
Safilo has officially launched the new David Beckham Eyewear collection in Australia, bringing a new range of sunglass and optical offerings to the premium male segment. Read more
Aussie corneal engineering research earns major backing
A Melbourne researcher has received a major funding boost to progress development of a tissue-engineered corneal endothelium for transplant, which could help overcome a global shortage of corneal donations in future. Read more
Lack of funding for non-clinical support revealed in Indigenous eye health review
A new Indigenous eye health study has recommended greater financial backing for non-clinical support providers, a critical factor that has been linked to improved patient appointment attendance.
Read more
National survey sheds new light on ophthalmology training
Ophthalmology trainees have indicated a high rate of satisfaction with their Vocational Training Program, according to the results of Australia’s first Medical Training Survey, released earlier this month. Read more
Study highlights biomarker for discontinuing anti-VEGF treatment
A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients can discontinue their anti-VEGF therapy. Read more
George & Matilda encourages staff to support fire affected communities
George & Matilda has created a new initiative to support communities affected by the 2020 bushfires by incentivising staff to get out and visit impacted regions. Read more
Australian CL manufacturer pens long-term deal with Chinese medical firm
Australia’s Capricornia Contact Lens is set to take its specialty products to the lucrative Chinese market after signing a 10-year distribution deal with a major pharmaceutical and medical equipment distributer. Read more
Commission probes proposed EssilorLuxottica-GrandVision acquisition
EssilorLuxottica has reaffirmed its goal to complete the acquisition of optical retail giant GrandVision within the next 18 months following the announcement of a new investigation by the European competition watchdog. Read more